Cargando…

Atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy

BACKGROUND: Atrial tachyarrhythmias (ATAs) are associated with an increased risk of incident heart failure (HF). The aim of this study was to evaluate the incidence of ATAs and time of ATA development during disease progression as well as the influence of ATAs on HF-related events in patients with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikuchi, Noriko, Shiga, Tsuyoshi, Suzuki, Atsushi, Hagiwara, Nobuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653060/
https://www.ncbi.nlm.nih.gov/pubmed/33204820
http://dx.doi.org/10.1016/j.ijcha.2020.100669
_version_ 1783607823535439872
author Kikuchi, Noriko
Shiga, Tsuyoshi
Suzuki, Atsushi
Hagiwara, Nobuhisa
author_facet Kikuchi, Noriko
Shiga, Tsuyoshi
Suzuki, Atsushi
Hagiwara, Nobuhisa
author_sort Kikuchi, Noriko
collection PubMed
description BACKGROUND: Atrial tachyarrhythmias (ATAs) are associated with an increased risk of incident heart failure (HF). The aim of this study was to evaluate the incidence of ATAs and time of ATA development during disease progression as well as the influence of ATAs on HF-related events in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). METHODS: We retrospectively studied 90 ARVC patients who met the definitive diagnosis of the 2010 Task Force Criteria and were diagnosed with ARVC at our institutions between 1974 and 2012. The main outcomes were death due to HF and hospitalization due to worsening HF. RESULTS: Eleven patients had a history of ATAs at the time of ARVC diagnosis. Of 79 patients without a prediagnosis history of ATAs, 21 (27%) newly experienced ATAs during a median follow-up period of 11.4 (range, 0.1–29.6) years. Among them, 15 patients experienced their first hospitalization due to worsening HF a median of 1.7 (range, 0.0–9.8) years after the occurrence of ATAs. Patients with ATAs were more likely to experience death due to HF and hospitalization due to worsening HF than patients without ATAs (odds ratio 19.2, 95% confidence interval 2.0–92.3, P < 0.01 and odds ratio 29.7, 95% confidence interval 8.4–104.8, P < 0.01, respectively). Multivariable analysis revealed that ATAs were associated with an increased risk of hospitalization due to worsening HF (hazard ratio 15.55, 95% confidence interval 4.82–50.17, P < 0.01). CONCLUSIONS: Our study suggests that the occurrence of ATAs is associated with an increased risk of HF-related events and worsens the prognosis of ARVC patients.
format Online
Article
Text
id pubmed-7653060
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-76530602020-11-16 Atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy Kikuchi, Noriko Shiga, Tsuyoshi Suzuki, Atsushi Hagiwara, Nobuhisa Int J Cardiol Heart Vasc Original Paper BACKGROUND: Atrial tachyarrhythmias (ATAs) are associated with an increased risk of incident heart failure (HF). The aim of this study was to evaluate the incidence of ATAs and time of ATA development during disease progression as well as the influence of ATAs on HF-related events in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). METHODS: We retrospectively studied 90 ARVC patients who met the definitive diagnosis of the 2010 Task Force Criteria and were diagnosed with ARVC at our institutions between 1974 and 2012. The main outcomes were death due to HF and hospitalization due to worsening HF. RESULTS: Eleven patients had a history of ATAs at the time of ARVC diagnosis. Of 79 patients without a prediagnosis history of ATAs, 21 (27%) newly experienced ATAs during a median follow-up period of 11.4 (range, 0.1–29.6) years. Among them, 15 patients experienced their first hospitalization due to worsening HF a median of 1.7 (range, 0.0–9.8) years after the occurrence of ATAs. Patients with ATAs were more likely to experience death due to HF and hospitalization due to worsening HF than patients without ATAs (odds ratio 19.2, 95% confidence interval 2.0–92.3, P < 0.01 and odds ratio 29.7, 95% confidence interval 8.4–104.8, P < 0.01, respectively). Multivariable analysis revealed that ATAs were associated with an increased risk of hospitalization due to worsening HF (hazard ratio 15.55, 95% confidence interval 4.82–50.17, P < 0.01). CONCLUSIONS: Our study suggests that the occurrence of ATAs is associated with an increased risk of HF-related events and worsens the prognosis of ARVC patients. Elsevier 2020-11-06 /pmc/articles/PMC7653060/ /pubmed/33204820 http://dx.doi.org/10.1016/j.ijcha.2020.100669 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Paper
Kikuchi, Noriko
Shiga, Tsuyoshi
Suzuki, Atsushi
Hagiwara, Nobuhisa
Atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy
title Atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy
title_full Atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy
title_fullStr Atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy
title_full_unstemmed Atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy
title_short Atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy
title_sort atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653060/
https://www.ncbi.nlm.nih.gov/pubmed/33204820
http://dx.doi.org/10.1016/j.ijcha.2020.100669
work_keys_str_mv AT kikuchinoriko atrialtachyarrhythmiasandheartfailureeventsinpatientswitharrhythmogenicrightventricularcardiomyopathy
AT shigatsuyoshi atrialtachyarrhythmiasandheartfailureeventsinpatientswitharrhythmogenicrightventricularcardiomyopathy
AT suzukiatsushi atrialtachyarrhythmiasandheartfailureeventsinpatientswitharrhythmogenicrightventricularcardiomyopathy
AT hagiwaranobuhisa atrialtachyarrhythmiasandheartfailureeventsinpatientswitharrhythmogenicrightventricularcardiomyopathy